Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Carriage of the V279F null allele within the gene encoding Lp-PLA₂ is protective from coronary artery disease in South Korean males.

Jang Y, Waterworth D, Lee JE, Song K, Kim S, Kim HS, Park KW, Cho HJ, Oh IY, Park JE, Lee BS, Ku HJ, Shin DJ, Lee JH, Jee SH, Han BG, Jang HY, Cho EY, Vallance P, Whittaker J, Cardon L, Mooser V.

PLoS One. 2011 Apr 5;6(4):e18208. doi: 10.1371/journal.pone.0018208.

2.

The architecture of gene regulatory variation across multiple human tissues: the MuTHER study.

Nica AC, Parts L, Glass D, Nisbet J, Barrett A, Sekowska M, Travers M, Potter S, Grundberg E, Small K, Hedman AK, Bataille V, Tzenova Bell J, Surdulescu G, Dimas AS, Ingle C, Nestle FO, di Meglio P, Min JL, Wilk A, Hammond CJ, Hassanali N, Yang TP, Montgomery SB, O'Rahilly S, Lindgren CM, Zondervan KT, Soranzo N, Barroso I, Durbin R, Ahmadi K, Deloukas P, McCarthy MI, Dermitzakis ET, Spector TD; MuTHER Consortium.

PLoS Genet. 2011 Feb 3;7(2):e1002003. doi: 10.1371/journal.pgen.1002003.

3.

Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies.

Reilly MP, Li M, He J, Ferguson JF, Stylianou IM, Mehta NN, Burnett MS, Devaney JM, Knouff CW, Thompson JR, Horne BD, Stewart AF, Assimes TL, Wild PS, Allayee H, Nitschke PL, Patel RS; Myocardial Infarction Genetics Consortium; Wellcome Trust Case Control Consortium, Martinelli N, Girelli D, Quyyumi AA, Anderson JL, Erdmann J, Hall AS, Schunkert H, Quertermous T, Blankenberg S, Hazen SL, Roberts R, Kathiresan S, Samani NJ, Epstein SE, Rader DJ.

Lancet. 2011 Jan 29;377(9763):383-92. doi: 10.1016/S0140-6736(10)61996-4. Epub 2011 Jan 14.

4.

PLA2G7 gene polymorphisms and coronary heart disease risk: a meta-analysis.

Wang Q, Hao Y, Mo X, Wang L, Lu X, Huang J, Cao J, Li H, Gu D.

Thromb Res. 2010 Dec;126(6):498-503. doi: 10.1016/j.thromres.2010.09.009.

PMID:
20926117
5.

Relation of plasma fatty acid binding proteins 4 and 5 with the metabolic syndrome, inflammation and coronary calcium in patients with type-2 diabetes mellitus.

Bagheri R, Qasim AN, Mehta NN, Terembula K, Kapoor S, Braunstein S, Schutta M, Iqbal N, Lehrke M, Reilly MP.

Am J Cardiol. 2010 Oct 15;106(8):1118-23. doi: 10.1016/j.amjcard.2010.06.028.

6.

Association of the vitamin D metabolism gene CYP24A1 with coronary artery calcification.

Shen H, Bielak LF, Ferguson JF, Streeten EA, Yerges-Armstrong LM, Liu J, Post W, O'Connell JR, Hixson JE, Kardia SL, Sun YV, Jhun MA, Wang X, Mehta NN, Li M, Koller DL, Hakonarson H, Keating BJ, Rader DJ, Shuldiner AR, Peyser PA, Reilly MP, Mitchell BD.

Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2648-54. doi: 10.1161/ATVBAHA.110.211805. Epub 2010 Sep 16.

7.

METAL: fast and efficient meta-analysis of genomewide association scans.

Willer CJ, Li Y, Abecasis GR.

Bioinformatics. 2010 Sep 1;26(17):2190-1. doi: 10.1093/bioinformatics/btq340. Epub 2010 Jul 8.

8.

Association of carotid plaque Lp-PLA(2) with macrophages and Chlamydia pneumoniae infection among patients at risk for stroke.

Atik B, Johnston SC, Dean D.

PLoS One. 2010 Jun 9;5(6):e11026. doi: 10.1371/journal.pone.0011026.

9.

PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of European Ancestry.

Casas JP, Ninio E, Panayiotou A, Palmen J, Cooper JA, Ricketts SL, Sofat R, Nicolaides AN, Corsetti JP, Fowkes FG, Tzoulaki I, Kumari M, Brunner EJ, Kivimaki M, Marmot MG, Hoffmann MM, Winkler K, März W, Ye S, Stirnadel HA, Boekholdt SM, Khaw KT, Humphries SE, Sandhu MS, Hingorani AD, Talmud PJ.

Circulation. 2010 Jun 1;121(21):2284-93. doi: 10.1161/CIRCULATIONAHA.109.923383. Epub 2010 May 17. Erratum in: Circulation. 2010 Jul 20;122(3):e400. Boekholdt, S Matthijs [added].

10.

Genome-wide association study of Lp-PLA(2) activity and mass in the Framingham Heart Study.

Suchindran S, Rivedal D, Guyton JR, Milledge T, Gao X, Benjamin A, Rowell J, Ginsburg GS, McCarthy JJ.

PLoS Genet. 2010 Apr 29;6(4):e1000928. doi: 10.1371/journal.pgen.1000928.

11.

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.

Lp-PLA(2) Studies Collaboration, Thompson A, Gao P, Orfei L, Watson S, Di Angelantonio E, Kaptoge S, Ballantyne C, Cannon CP, Criqui M, Cushman M, Hofman A, Packard C, Thompson SG, Collins R, Danesh J.

Lancet. 2010 May 1;375(9725):1536-44. doi: 10.1016/S0140-6736(10)60319-4.

12.

Experimental endotoxemia induces adipose inflammation and insulin resistance in humans.

Mehta NN, McGillicuddy FC, Anderson PD, Hinkle CC, Shah R, Pruscino L, Tabita-Martinez J, Sellers KF, Rickels MR, Reilly MP.

Diabetes. 2010 Jan;59(1):172-81. doi: 10.2337/db09-0367. Epub 2009 Sep 30.

13.

Association of PLA2G7 polymorphisms with carotid atherosclerosis in hypertensive Japanese.

Miwa Y, Kamide K, Takiuchi S, Yoshii M, Horio T, Tanaka C, Banno M, Miyata T, Kawano Y.

Hypertens Res. 2009 Dec;32(12):1112-8. doi: 10.1038/hr.2009.151. Epub 2009 Sep 18.

PMID:
19763134
14.

Lipoprotein-associated phospholipase A(2) and atherosclerosis.

Wilensky RL, Macphee CH.

Curr Opin Lipidol. 2009 Oct;20(5):415-20. doi: 10.1097/MOL.0b013e3283307c16. Review.

PMID:
19667981
15.

Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease.

Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC, Peden JF, Erdmann J, Braund P, Engert JC, Bennett D, Coin L, Ashby D, Tzoulaki I, Brown IJ, Mt-Isa S, McCarthy MI, Peltonen L, Freimer NB, Farrall M, Ruokonen A, Hamsten A, Lim N, Froguel P, Waterworth DM, Vollenweider P, Waeber G, Jarvelin MR, Mooser V, Scott J, Hall AS, Schunkert H, Anand SS, Collins R, Samani NJ, Watkins H, Kooner JS.

JAMA. 2009 Jul 1;302(1):37-48. doi: 10.1001/jama.2009.954.

16.

The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma.

Tellis CC, Tselepis AD.

Biochim Biophys Acta. 2009 May;1791(5):327-38. doi: 10.1016/j.bbalip.2009.02.015. Review.

PMID:
19272461
17.

Tissue-specific genetic control of splicing: implications for the study of complex traits.

Heinzen EL, Ge D, Cronin KD, Maia JM, Shianna KV, Gabriel WN, Welsh-Bohmer KA, Hulette CM, Denny TN, Goldstein DB.

PLoS Biol. 2008 Dec 23;6(12):e1. doi: 10.1371/journal.pbio.1000001.

18.

Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies.

Keating BJ, Tischfield S, Murray SS, Bhangale T, Price TS, Glessner JT, Galver L, Barrett JC, Grant SF, Farlow DN, Chandrupatla HR, Hansen M, Ajmal S, Papanicolaou GJ, Guo Y, Li M, Derohannessian S, de Bakker PI, Bailey SD, Montpetit A, Edmondson AC, Taylor K, Gai X, Wang SS, Fornage M, Shaikh T, Groop L, Boehnke M, Hall AS, Hattersley AT, Frackelton E, Patterson N, Chiang CW, Kim CE, Fabsitz RR, Ouwehand W, Price AL, Munroe P, Caulfield M, Drake T, Boerwinkle E, Reich D, Whitehead AS, Cappola TP, Samani NJ, Lusis AJ, Schadt E, Wilson JG, Koenig W, McCarthy MI, Kathiresan S, Gabriel SB, Hakonarson H, Anand SS, Reilly M, Engert JC, Nickerson DA, Rader DJ, Hirschhorn JN, Fitzgerald GA.

PLoS One. 2008;3(10):e3583. doi: 10.1371/journal.pone.0003583. Epub 2008 Oct 31.

19.

Genetically elevated C-reactive protein and ischemic vascular disease.

Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG.

N Engl J Med. 2008 Oct 30;359(18):1897-908. doi: 10.1056/NEJMoa0707402.

20.

Lipoprotein-associated and secretory phospholipase A2 in cardiovascular disease: the epidemiological evidence.

Koenig W, Khuseyinova N.

Cardiovasc Drugs Ther. 2009 Feb;23(1):85-92. doi: 10.1007/s10557-008-6135-6. Epub 2008 Oct 24. Review.

PMID:
18949547
Items per page

Supplemental Content

Write to the Help Desk